Health and Fitness Health and Fitness
Tue, September 25, 2012
Mon, September 24, 2012
[ Mon, Sep 24th 2012 ] - Market Wire
PG&E Promotes Safe Communities
[ Mon, Sep 24th 2012 ] - Market Wire
40 a.m. ET

Navidea Biopharmaceuticals Posts Lymphoseek®; NDA Update to Company Website


Published on 2012-09-24 12:00:25 - Market Wire
  Print publication without navigation


DUBLIN, Ohio--([ ])--Navidea Biopharmaceuticals, Inc. (NYSEMKT: NAVB), a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents, today posted on its website an update to the status of the Lymphoseek NDA review. The web access to the statement can be found on the Navidea Investor page at: [ http://phx.corporate-ir.net/phoenix.zhtml?c=68527&p=irol-nda ].